Tissue-based activation of mucosal-associated invariant T (MAIT) cells in combination ipilimumab and nivolumab checkpoint inhibitor (CI) colitis
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Conference item |
Language: | English |
Published: |
Elsevier
2019
|